In trading on Thursday, shares of the Direxion Daily Financial Bull 3X Shares ETF (Symbol: FAS) crossed below their 200 day moving average of $143.22, changing hands as low as $139.00 per share.

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience. To access our Live RNS you must confirm you are a private ...

The Trump administration has begun a broad examination of almost $9 billion in federal aid to Harvard University, escalating its drive against what it deems is the failure of elite institutions to ...

Acoramidis’s hazard ratio of .41 for time to ACM or first CVH versus placebo in the ATTRibute-CM study subgroup of ATTRv-CM patients achieved statistical significance in a pre-specified analysis ...

“Variant ATTR-CM patients’ condition often presents at an earlier age and progresses more rapidly than patients with wild-type disease, which translates into a worse prognosis in many such patient ...

One of Crystal Palace or Aston Villa will play in the FA Cup final, with Nottingham Forest taking on Manchester City in the other semi-final at Wembley. Palace enjoyed a brilliant 3-0 win at ...

Follow the game back with Standard Sport’s LIVE blog below! Manchester City are through to yet another FA Cup semi-final after coming from behind to beat Bournemouth. Pep Guardiola’s side were ...

The FA Cup represents City’s last chance to salvage something from a frustrating season but they have been handed a tough draw away at the Vitality Stadium. Bournemouth came out on top when ...

CHICAGO—Researchers detailed the histological, cellular, and molecular effects of tafamidis therapy in 20 patients with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) and coexisting atrial ...

TOKYO - The Japanese Ministry of Health, Labour and Welfare has granted approval to BridgeBio Pharma, Inc.’s acoramidis, marketed under the brand name Beyonttra, for the treatment of adults with ...

France is providing Ukraine with a new military aid package worth €2 billion, French President Emmanuel Macron announced during a press conference with Ukrainian President Volodymyr Zelenskyy. "Today, ...

A case report by Japanese authors demonstrates the strengths of tafamidis as a long-term drug in managing ATTR-CM. Transthyretin amyloid cardiomyopathy (ATTR-CM) raises the risk of early mortality ...